OquiliaOquiliaOquilia — India's Financial Intelligence Platform
Calculators
Compare
Tax
NRI
News
Consult
Oquilia Advisor
HomeCalculatorsConsultNews

Talk to Subodh Bajpai · Advocate

Free 15-min phone consultation. No payment, no signup.

+91 84008 60008Or view paid consultations from ₹5,000 →
View All CalculatorsSIP CalculatorEMI CalculatorIncome TaxFD CalculatorPPF CalculatorAll 150+ Calculators
View All CompareHome Loan RatesPersonal LoansCredit CardsHealth InsuranceTerm InsuranceMutual FundsFD RatesEducation Loan
View All TaxOld vs New RegimeTax Saving under 80CIncome Tax Slabs 2025Capital Gains TaxSave Tax on SalaryITR Filing Guide
View All NRINRI Investment GuideNRI Tax FilingNRI Banking & NRE FDNRI Real EstateDTAA CalculatorNRE FD Calculator
View All NewsLatest NewsSubodh's Law ColumnSARFAESI DefenceBlog / GuidesReports
View All ConsultFree 15-min call · +91 84008 60008DTAA Review · ₹5,000FEMA Compounding · ₹15,000NRI Tax Filing Review · ₹7,500About Subodh Bajpai, Advocate
View All ToolsAm I Underinsured?Policy AuditJargon DecoderMutual Fund Discovery
For Business
View All LearnFinancial GlossaryFAQAbout OquiliaContact
Oquilia Advisor
  1. Home
  2. News
  3. Bezos's Prometheus Raises $12B for Physical AI at $41B Value
Startups

Bezos's Prometheus Raises $12B for Physical AI at $41B Value

Jeff Bezos's two-year-old physical-AI venture just raised $12 billion at a $41 billion valuation. For India's stalled jet-engine and drug-discovery ambitions, it is a wake-up call.

Oquilia Newsroom
Financial news desk covering SEBI, RBI, IRDAI, and Budget-related developments.
|3 min read · 732 words
Verified Sources|Last reviewed: 12 June 2026
Bezos's Prometheus Raises $12B for Physical AI at $41B Value — Startups on Oquilia

The News

Jeff Bezos has put his name and his chequebook behind one of the largest private fundraises the technology industry has ever seen. Prometheus, the physical-AI company he co-founded with Vik Bajaj, has closed a $12 billion Series B that values the two-year-old business at $41 billion.

The raise lands just months after a $6.2 billion Series A launched in late 2025, an unusually rapid back-to-back that underlines how aggressively investors are chasing the idea. JPMorgan Chase, Goldman Sachs and BlackRock all joined the round, alongside a personal cheque from Bezos himself. The company employs roughly 150 people across offices in San Francisco, London and Zurich.

What Prometheus wants to build is an "artificial general engineer": software that can design and help manufacture complex physical systems with little human input. The early targets are audacious, spanning jet engines, new drug compounds and heavy industrial engineering.

Why It Matters

Two numbers tell the story of how far expectations have run ahead of revenue. A $41 billion valuation places Prometheus among the most richly priced AI startups in the world, and it has reached that mark before demonstrating a single commercial product at scale. The bet is not on what the company sells today but on whether software can compress the slow, capital-heavy work of physical engineering the way it has already compressed writing code.

For decades the constraint on building better engines, drugs and machines has been the scarcity of elite human engineers and the years it takes them to iterate. An artificial general engineer promises to collapse that timeline. Bezos has framed the upside starkly, arguing that "significant productivity" will raise living standards and could even create a "labour scarcity" in which demand for workers outstrips supply.

The last time investors poured this much conviction into a single unproven category was the generative-AI rush that followed ChatGPT in late 2022, when valuations detached from revenue almost overnight. Physical AI is now having that moment, and Prometheus is its flagbearer.

Indian Angle

For India, the most pointed signal sits in that list of target applications: jet engines. India has spent more than three decades trying to build an indigenous fighter-jet engine through the Kaveri programme, only to keep returning to foreign suppliers. A tool that can meaningfully accelerate propulsion design would be transformative for bodies such as DRDO's Gas Turbine Research Establishment and Hindustan Aeronautics, yet it could also deepen dependence on another foreign-owned capability if domestic equivalents never emerge.

Drug design is the second hook. Indian pharmaceutical majors such as Sun Pharma and Dr Reddy's built global businesses on manufacturing scale and generics, not on discovery. AI-led compound design is exactly where the next competitive moat is forming, and where Indian firms risk being out-iterated unless they invest now. There is a talent dimension too: Indian-origin scientists are heavily represented at these frontier labs, and Bajaj's own career is a reminder of that pipeline.

For policymakers at MeitY steering the IndiaAI mission, Prometheus is a useful provocation. Public AI spending has concentrated on language models and compute. The physical-AI frontier, where software meets manufacturing, may be where industrial strategy and AI policy most need to converge.

FAQ

How much did Prometheus raise and at what valuation?

The company closed a $12 billion Series B at a $41 billion valuation. That follows a $6.2 billion Series A launched in late 2025, making it one of the most richly funded AI startups in the world despite being only two years old.

Who is behind the company?

Prometheus was co-founded by Jeff Bezos and Vik Bajaj, a former co-founder of Verily, Google's life-sciences unit. Bezos invested personally, joined by JPMorgan Chase, Goldman Sachs and BlackRock. The firm has around 150 staff in San Francisco, London and Zurich.

What is an "artificial general engineer"?

It is the company's term for software that can design and help manufacture complex physical systems, from jet engines to drug compounds, with minimal human input. The aim is to do for physical engineering what code-generation tools have done for software.

Why does this matter for India?

The target applications, jet engines and drug discovery, map directly onto two of India's industrial ambitions and weaknesses. It raises questions for HAL, DRDO, pharma majors and the IndiaAI mission about whether to build comparable capability at home.

This story was reported by TechCrunch. Read the full original coverage at TechCrunch.

Sources & Citations

  1. Jeff Bezos's Prometheus raises $12B to build an 'artificial general engineer' for the physical world — TechCrunch

This article was last reviewed on 12 June 2026by Oquilia's editorial team. Every claim is sourced from primary regulatory materials (CBDT, IRDAI, RBI, SEBI, Indian Kanoon). View our methodology.

Found an error? Report an issue.

CalculatorsInsuranceInvestTaxLoansNRIMBAHNIAI
Oquilia

150+ calculators · Zero commissions

Oquilia

Intelligent financial analysis. 150+ calculators & unbiased analysis.

Data: IRDAI · RBI · SEBI · AMFI

Calculators

  • SIP
  • EMI
  • Income Tax
  • FD
  • PPF
  • NPS
  • Gratuity
  • HRA
  • ELSS
  • All 150+

Insurance

  • Compare Plans
  • Companies
  • Claims Data
  • Hospitals
  • Health Premium
  • Term Premium
  • Section 80D

Tax & Loans

  • Old vs New
  • Capital Gains
  • TDS
  • Home Loan EMI
  • Car Loan EMI
  • Rent vs Buy
  • Prepayment

More Tools

  • Invest Hub
  • Tax Planning
  • Loan Tools
  • Loan Harassment Help
  • NRI Hub
  • MBA Finance
  • HNI Wealth
  • Glossary
  • News
  • Blog
  • Reports
  • Tools
  • Oquilia Advisor

Company

  • About
  • Contact
  • FAQ
  • Legal Hub
  • Privacy
  • Terms
  • Disclaimer
  • Cookie Policy
  • Grievance
  • Disclosure

Newsletter

Monthly digest

Policy moves, deadline reminders, and the most-used calculators each month.

Reviewed by Subodh Bajpai, Senior Partner & MBA Finance (XLRI)

Legal & Grievance Partner: Unified Chambers & Associates, Delhi High Court

Designed & developed by QX137, React & Next.js studio

Regulatory & data sources

RBISEBIIRDAIIncome Tax DeptAMFIPFRDAOECD TaxBISWorld Bank

Regulatory data last updated: May 2026. Figures are cross-checked against primary IRDAI, SEBI, RBI, CBDT and AMFI publications before they ship.

© 2026 Oquilia. Not a licensed financial advisor. All third-party logos and trademarks belong to their respective owners.

PrivacyTermsDisclaimerSitemap